期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

冠状动脉慢血流型心绞痛的研究进展 被引量：6

下载PDF
导出
摘要 冠状动脉慢血流（coronary slow flow，CSF）现象是指正常或接近正常的冠状动脉在冠状动脉造影中出现的血流灌注延迟现象。80%～90%CSF患者长期反复发作心绞痛，约1/3的患者会因急性加重而反复住院[1]。临床实践中，对此类患者的诊断、归类往往模糊不清。现将此类心绞痛称为冠状动脉慢血流型心绞痛（coronary slow flow angina，CSFA）[2]。CSFA是微血管心绞痛谱中重要的亚型。
作者 吕慧 柴婵娟 杨志明
机构地区 山西医科大学第二医院心内科
出处 《中国介入心脏病学杂志》 2014年第10期654-656,共3页 Chinese Journal of Interventional Cardiology
关键词 冠状动脉慢血流 心绞痛 微循环障碍
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献31

  • 1Beltrame JF, Limaye SB, Wuttke RD, et al. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J, 2003, 146:84-90.
  • 2Yang Zhiming, Gong Shuwen, Zhu Guobin, et al. Slow coronary flow angina. Chinese Medical Journal, 2013, 126:198.
  • 3Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon - a new coronary microvascular disorder. Cardiology, 2002, 97:197-202.
  • 4Ozcan T, Gen R, Akbay E, et al. The correlation of thrombolysis in myocardial infarction frame count with insulin resistance in patients with slow coronary flow. Coron Artery Dis, 2008, 19:591-595.
  • 5L.Khor, R.tavella, :l.Beltrame. Long term outcomes in patients with the coronary slow flow phenomenon. Heart Lung Circ, 2013, 22: s126-s266.
  • 6Tambe AA, Demany MA, Zimmerman HA, et al. Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding. Am Heart J, 1972, 84:66-71.
  • 7Mosseri M, Yarom R, GotsmanMS, et al. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation, 1986, 74:964-972.
  • 8Yazici M, Demircan S, Duma K, et al. The role of adrenergic activityin slow coronary flow and its relationship to TIMI frame count. Angiology, 2007, 58:393-400.
  • 9Sezgin AT, Sigirci A, Barutcu I, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis, 2003, 14:155- 161.
  • 10Camsari A, Ozcan T, Ozer C, et al. Carotid artery intima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis, 2008, 200:310- 314.

二级参考文献10

  • 1Assali AR,Sdringola S,Ghani M,et al. Intracoronary adenosineadministered during percutaneous intervention in acute myocardialinfarction and reduction in the incidence of 〃no-reflow〃phenomenon. Cathet Cardiovasc Interv, 2000, 51:27-31.
  • 2Morishima I,Sane T, Okumura K, et al. Angiographic no-reflowphenomenon as a predictor of adverse long-term outcome inpatients treated with percutaneous transluminal coronaryangioplasty for first acute myocardial infarction. Am Coil Cardiol,2000, 36:12 022-12 029.
  • 3Butler MJ,Chan W, Taylor AJ, et al. Management of the no-reflow phenomenon. Pharmacol Ther, 2011,132:72-85.
  • 4Napodano M, Pasquetto G, Saccd S, et al. Intracoronarythrombectomy improves myocardial reperfusion in patientsundergoing direct angioplasty for acute myocardial infarction. JAm Col 1 Caixliol, 2003, 42 : 1395-1402.
  • 5van Ommen V,Michels R, Heymen E, et al. Usefulness of therescue PT catheter to remove fresh thrombus from coronaryarteries and bypass graft s in acute myocardial infarction. Am JCardiol, 2001, 88: 306-308.
  • 6Limbruno U,De Carlo M, Pistolesi S, et al. Distal embolizationduring primary angioplasty: histopathologic features andpredictability. Am Heart J, 2005, 150:102-108.
  • 7De Luca G, Navarese EP, Suryapranata H. A meta-analyticoverview of thrombectomy during primary angioplasty. Int JCardiol, 2012,doi:10. 1016/j. ijcard.2011. 11. 102.
  • 8Wong P,Harding S, Inglessis I, et al. The effect of glycoproteinII b/M a receptor inhibitor on the microcirculation in patientsundergoing high-risk coronary stentiong ; a prospective,radomized study. J Thromb Thrombolysis, 2003 , 16 : 163-166.
  • 9Wang Y,Wu B, Shu X. Meta-analysis of randomized controlledtrials comparing intracoronary and intravenous administration ofglycoprotein II b/HI a inhibitors in patients with ST-elevationmyocardial infarction. Am J Cardiol, 2012, 109: 1124-1130.
  • 10Van't Hof AW,Ten Berg J, Heestermans T, et al. Prehospitalinitiation of tirofiban in patients with ST-elevation myocardialinfarction undergoing primary angioplasty ( On-TIME 2 ) : amulticentre, double-blind, randomised controlled trial. Lancet,2008,372:537-546.

共引文献4

同被引文献46

  • 1马晓海,张兆琪,赵轶柯,李铁铮,柳宏,陈韵岱,晏子旭.冠状动脉血流储备与管腔狭窄关系的MR研究[J].中华放射学杂志,2005,39(6):582-587. 被引量：2
  • 2Bolognese L,Carrabba N,Parodi G,et al.Impact of microvascular dysfunction on left ventricular remodeling and longterm clinical outcome after primary coronary angioplasty for acute myocardial infarction.Circulation,2004,109:1121-1126.
  • 3Hombach V,Grebe O,Merkle N,et al.Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging.Eur Heart J,2005,26:549-557.
  • 4Gibson CM,Cannon CP,Murphy SA,et al.Relationship of the TIMI myocardial perfusion grades,flow grades,frame count,and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.Circulation,2002,105:1909-1913.
  • 5Svilaas T,Vlaar PJ,vander Horst IC,et al.Thrombus aspiration during primary percutaneous coronary intervention.N Engl J Med,2008,358:557-567.
  • 6Steg PG,James S,Harrington RA,et al.Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention:A Platelet Inhibition and Patient Outcomes(PLATO)trial subgroup analysis.Circulation,2010,122:2131-2141.
  • 7Storey RF,Angiolillo DJ,Patil SB,et al.Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes:the PLATO(PLATelet inhibition and patient Outcomes)PLATELET substudy.J Am Coll Cardiol,2010,56:1456-1462.
  • 8O'Gara PT,Kushner FG,Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST elevation myocardial infarction.J Am Coll Cardiol,2013,61:e78-e140.
  • 9Mehran R,Rao SV,Bhatt DL,et al.Standardized bleeding definitions for cardiovascular clinical trials:a consensus report from the Bleeding Academic Research Consortium.Circulation,2011,123:2736-2747.
  • 10Abdi S,Rafizadeh O,Peighambari M,et al.Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention.Res Cardiovasc Med,2015,4:e25414.

引证文献6

二级引证文献54

中国介入心脏病学杂志
2014年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部